|
MYO10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.115490E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.346080E-02 |
| Stage1-vs-Stage3 |
2.387900E-02 |
| Stage1-vs-Stage4 |
4.766600E-04 |
| Stage2-vs-Stage3 |
6.768000E-04 |
| Stage2-vs-Stage4 |
6.34250000000058E-05 |
| Stage3-vs-Stage4 |
1.922850E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.41769995742891E-09 |
| Normal-vs-Asian |
1.69542158090508E-12 |
| Caucasian-vs-AfricanAmerican |
9.436200E-01 |
| Caucasian-vs-Asian |
6.739800E-01 |
| AfricanAmerican-vs-Asian |
8.021600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.530509218308E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.948400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64146474190829E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63313806922361E-12 |
| Normal-vs-Age(81-100Yrs) |
7.54240000000461E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.786000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.714400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.508000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.061000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.942400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.014800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.61929999999267E-05 |
| Classical-VS-Follicular |
4.10049999999273E-06 |
| Classical-VS-Other |
8.414400E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.41620049021185E-10 |
| Tall-VS-Other |
2.306600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.979760E-01 |
| Follicular-VS-Normal |
1.001260E-04 |
| Other-VS-Normal |
4.158400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84274817627283E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.76739999999876E-05 |
|
|
